Hermetica Superfood Encyclopedia
The Short Answer
Macaranga species produce over 190 secondary metabolites—prominently C-prenylated flavonoids such as isomacarangin and nymphaeols A/B/C, and stilbenes such as schweinfurthin B—that exert antimicrobial activity via membrane disruption and antioxidant activity via free-radical scavenging, with in vitro MICs as low as 62.5 µg/mL against Staphylococcus aureus for schweinfurthin B. The bark sap has been used ethnobotanically in Papua New Guinea to induce labor, while preclinical assays demonstrate antioxidant potency in M. peltata methanolic extract exceeding that of reference standards ascorbic acid and quercetin under DPPH radical scavenging conditions.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordMacaranga benefits
Macaranga — botanical close-up
Health Benefits
**Antimicrobial Activity**
The prenylated flavonoid isomacarangin and stilbene schweinfurthin B inhibit gram-positive bacteria including S. aureus at MICs of 62.5–125 µg/mL in vitro, with enhanced membrane penetration attributed to the hydrophobic prenyl substituents on the flavonoid scaffold.
**Antioxidant Protection**: Methanolic extracts of M
peltata demonstrate DPPH radical scavenging capacity surpassing ascorbic acid and quercetin as reference antioxidants, while M. hosei methanol extract achieves a superoxide scavenging SC50 of 25.8 ppm, suggesting potent electron-donating capacity from polyphenolic and tannin constituents.
**Anti-inflammatory Potential**: Nymphaeol-class prenylated flavonoids from M
tanarius inhibit albumin denaturation with IC50 values of 0.26–1.02 mM, a mechanistic proxy for suppression of inflammation-associated protein conformational changes and potential modulation of inflammatory proteases.
**Uterotonic/Labor-Induction Use**
Bark sap preparations are employed in Papua New Guinean traditional medicine to stimulate uterine contractions and facilitate parturition, though the specific bioactive constituents and molecular targets responsible for this uterotonic effect have not yet been isolated or characterized in controlled studies.
**Antifungal Activity**
In vitro comparisons with fluconazole indicate that certain Macaranga extracts and isolated compounds exhibit antifungal properties, with active fractions demonstrating inhibition of fungal growth at concentrations of 250–1000 µg/mL, though specific fungal species data remain limited.
**Cosmetic and Dermoprotective Potential**
The combined antioxidant and anti-inflammatory profile of Macaranga leaf extracts has prompted proposals for their incorporation into topical cosmetic formulations, with nanotechnology-based delivery systems suggested to improve extract stability, though these applications remain at a conceptual and preliminary experimental stage.
**Anticancer Preclinical Signals**
Schweinfurthin-class stilbenes identified in Macaranga species have attracted interest for cytotoxic activity in related genus research contexts, with structural analogs showing activity against cancer cell lines in preclinical settings, though direct in vivo anticancer evidence for Macaranga-derived schweinfurthins is not yet robustly established.
Origin & History
Natural habitat
Macaranga is a large genus of approximately 300 species within the family Euphorbiaceae, distributed across tropical and subtropical regions of Africa, Asia, the Pacific Islands, and Australia, with particularly high species diversity in Southeast Asia and Melanesia including Papua New Guinea and Indonesia. Species such as Macaranga tanarius, M. peltata, and M. hosei thrive in lowland tropical rainforests, secondary growth habitats, forest margins, and disturbed areas, often functioning as pioneer species in cleared or regenerating forest ecosystems. Traditional cultivation is largely incidental; indigenous communities in Papua New Guinea, Indonesia, and the broader Pacific Islands harvest bark, leaves, and sap directly from wild-growing trees rather than from cultivated stands.
“Within Papua New Guinea and broader Melanesian communities, Macaranga trees hold practical ethnobotanical significance as sources of medicinal bark sap traditionally administered by birth attendants and traditional healers to facilitate and accelerate labor in pregnant women, representing a well-documented but pharmacologically uncharacterized obstetric practice. In Indonesia and other parts of Southeast Asia, various Macaranga species have been employed in unspecified traditional remedies for conditions including skin ailments, infections, and inflammatory complaints, with leaves and bark being the most commonly utilized plant parts. The genus name Macaranga derives from a Malagasy vernacular term, reflecting early botanical documentation of the genus in Madagascar, and the species have also figured in agroecological knowledge systems as fast-growing pioneer trees used to shade and protect young crops in agroforestry systems across the Pacific. Scientific interest in Macaranga phytochemistry accelerated notably in the late 1990s and 2000s as researchers sought to characterize the structural diversity of prenylated flavonoids and stilbenes unique to this genus, contributing significantly to natural product chemistry even in the absence of clinical application development.”Traditional Medicine
Scientific Research
The current body of evidence for Macaranga consists exclusively of in vitro phytochemical and pharmacological studies; no clinical trials, randomized controlled trials, or controlled human studies have been conducted on any species within this genus for any indication. Published research has primarily focused on structural elucidation of secondary metabolites—over 190 compounds catalogued across the genus—alongside antimicrobial MIC determinations, DPPH/superoxide antioxidant assays, and protein denaturation inhibition assays, all conducted in laboratory settings without animal or human subjects. Quantitative data from these studies include schweinfurthin B MIC of 62.5 µg/mL against S. aureus, M. hosei methanol extract SC50 of 25.8 ppm for superoxide scavenging, and nymphaeol anti-denaturation IC50 values of 0.26–1.02 mM, but no pharmacokinetic parameters, bioavailability estimates, or therapeutic dose-response relationships in living organisms have been reported. The ethnobotanical claim of labor induction via bark sap in Papua New Guinea rests entirely on traditional use documentation without any controlled pharmacological validation, representing a significant gap in the evidence base.
Preparation & Dosage
Traditional preparation
**Traditional Bark Sap (Papua New Guinea)**
Fresh bark is incised or scraped to collect exuded sap, which is applied or administered by traditional practitioners to induce labor; no standardized volume, concentration, or dosing protocol has been documented or validated.
**Methanolic Leaf Extract (Research Use)**
Dried leaf material extracted with methanol (typically 70–100%) under maceration or Soxhlet conditions; used at concentrations of 62.5–1000 µg/mL in in vitro assays only; no human dose established.
**Ethyl Acetate (EtOAc) Fraction (Research Use)**
Partitioned from crude methanol extract; used in antimicrobial and antioxidant assays at similar concentration ranges; not formulated for human consumption.
**n-Butanol (n-BuOH) Fraction (Research Use)**
Active against E. coli at 250 µg/mL in vitro; isolated via liquid-liquid partitioning in laboratory settings.
**Column Chromatography Isolates**
Individual compounds such as isomacarangin, nymphaeols, schweinfurthins, and macatannins are obtained via silica gel or Sephadex column chromatography for pure compound testing; not available as consumer supplements.
**Proposed Nanoformulation (Cosmetic, Experimental)**
Nanotechnology-assisted encapsulation of antioxidant/anti-inflammatory Macaranga extracts for topical cosmetic use has been proposed but not validated or commercially developed.
**Standardization**
No pharmacopoeial monograph, standardized extract specification, or quality control marker has been established for any Macaranga species or preparation.
Nutritional Profile
Macaranga species are not consumed as food and have no documented nutritional profile in terms of macronutrients (proteins, carbohydrates, fats) or micronutrients (vitamins, minerals) relevant to dietary supplementation. The phytochemical profile is the primary focus of scientific characterization: flavonoids (isomacarangin, nymphaeol A/B/C, 3'-geranyl-naringenin and up to 84 additional compounds) represent the most diverse and quantitatively studied class, followed by stilbenes (schweinfurthin B, O, and related analogs, compounds 85–100), tannins including hydrolyzable ellagitannins such as chebulagic acid, macatannin B, and geraniinic acid derivatives (compounds 101–144), sesqui- and diterpenes (compounds 145–156), coumarins (compounds 157–158), steroids (compounds 159–161), and ellagic acid derivatives. Specific concentrations of these metabolites in raw plant tissue have not been reported in published literature; available quantitative data reflect extract yields and isolated compound activities rather than tissue-level phytochemical content. Bioavailability of any constituent after oral ingestion is entirely unstudied, and absorption, distribution, metabolism, and excretion parameters for Macaranga-derived compounds in humans or animal models have not been published.
How It Works
Mechanism of Action
C-prenylated flavonoids such as isomacarangin carry hydrophobic geranyl or prenyl side chains that increase lipophilicity, facilitating insertion into and disruption of bacterial phospholipid bilayers, thereby compromising membrane integrity and impairing cell viability at low micromolar-to-microgram concentrations. Polyphenolic constituents including tannins (macatannin B, chebulagic acid, geraniinic acid derivatives) and flavonoids contribute to antioxidant activity through hydrogen atom transfer and single-electron transfer mechanisms that neutralize superoxide anions and DPPH radicals, as quantified by DPPH, superoxide, and reducing power assays across multiple species. Anti-inflammatory effects attributed to nymphaeols A, B, and C involve inhibition of heat-induced albumin denaturation, suggesting interference with conformational activation of inflammatory proteins and possible downstream reduction of prostaglandin or cytokine signaling pathways, though specific enzyme targets such as COX-1/COX-2 or transcription factors such as NF-κB have not been confirmed experimentally for Macaranga-derived compounds. The uterotonic mechanism of bark sap used in Papua New Guinean obstetric practice remains pharmacologically uncharacterized, with no receptor binding data (e.g., oxytocin receptor, prostaglandin EP receptors) or smooth-muscle contractility assays yet published for identified Macaranga constituents.
Clinical Evidence
No clinical trials have been registered, conducted, or published examining any Macaranga species or derived extract in human subjects for any therapeutic indication, including the traditional use of bark sap for labor induction in Papua New Guinea. All available efficacy data originate from in vitro cell-free or cell-based assays measuring MIC values, IC50 parameters, and scavenging capacities, which, while informative for compound characterization, cannot be extrapolated to clinical efficacy or safety in humans without pharmacokinetic and toxicological bridging studies. The absence of animal model studies for most reported activities further limits the translational relevance of existing data, and no effect sizes, confidence intervals, or patient-relevant outcomes have been measured. Clinical confidence in any therapeutic application of Macaranga is therefore very low, and its use in labor induction or other medical contexts outside of traditional practice settings cannot be supported by current evidence.
Safety & Interactions
The safety profile of Macaranga preparations in humans is essentially unknown; published literature notes the potential for toxicity and phototoxic effects associated with certain constituents, but no systematic toxicological studies, NOAEL determinations, or maximum tolerated dose assessments have been conducted for any species or extract. No human adverse event reports, case series, or post-market surveillance data are available, and drug interaction studies do not exist beyond the use of fluconazole and ciprofloxacin as comparator antimicrobials in in vitro MIC assays, which cannot predict pharmacokinetic drug-herb interactions in vivo. The traditional use of bark sap for labor induction in Papua New Guinea constitutes a specific and significant contraindication concern: any uterotonic activity would render Macaranga preparations potentially dangerous during pregnancy outside of the intended peripartum context, and use during early or mid-pregnancy, or in individuals with pregnancy complications, cannot be considered safe without clinical study. Given the complete absence of safety data, Macaranga preparations in any form should not be used by pregnant individuals (except under traditional supervised practice), breastfeeding women, children, or individuals taking pharmaceutical medications without formal medical supervision and toxicological clearance.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Macaranga (Macaranga sp., family Euphorbiaceae)Macaranga hoseiMacaranga peltataMacaranga tanariusMacaranga sp.Coral tree (regional vernacular, some Pacific contexts)
Frequently Asked Questions
What is Macaranga used for in traditional medicine?
In Papua New Guinea, the bark sap of Macaranga trees is traditionally used by birth attendants to induce labor in pregnant women, representing one of the most documented ethnobotanical applications of the genus. In Indonesia and other parts of Southeast Asia, leaves and bark of various Macaranga species are used for unspecified skin conditions, infections, and inflammatory ailments, though these uses lack formal pharmacological documentation.
What are the active compounds in Macaranga?
Macaranga species contain over 190 identified secondary metabolites, with the most pharmacologically studied being C-prenylated flavonoids such as isomacarangin, nymphaeol A, B, and C, and 3'-geranyl-naringenin, as well as stilbenes including schweinfurthin B and schweinfurthin O. Additional compound classes include hydrolyzable tannins (chebulagic acid, macatannin B), terpenes, coumarins, steroids, and ellagic acid derivatives, which collectively contribute to the genus's observed antimicrobial and antioxidant activities.
Is there clinical trial evidence supporting Macaranga health benefits?
No clinical trials in human subjects have been conducted for any Macaranga species or preparation; all available evidence is limited to in vitro laboratory assays including antimicrobial MIC testing, DPPH and superoxide radical scavenging assays, and protein denaturation inhibition studies. While these preclinical results are scientifically interesting—schweinfurthin B achieves an MIC of 62.5 µg/mL against S. aureus and M. peltata extract surpasses ascorbic acid in DPPH assays—they cannot be extrapolated to human therapeutic efficacy without clinical investigation.
Is Macaranga safe to use during pregnancy?
Given that Macaranga bark sap is traditionally used specifically to induce uterine contractions and labor, any uterotonic activity would make it potentially hazardous during pregnancy outside of the intended term-labor context, posing a theoretical risk of premature labor or miscarriage in earlier pregnancy. No clinical safety data, toxicological studies, or pharmacovigilance records exist for Macaranga in pregnant or breastfeeding women, and its use outside of supervised traditional practice settings cannot be recommended.
What is the antioxidant potency of Macaranga compared to known standards?
In vitro antioxidant testing of Macaranga peltata methanolic extract demonstrated DPPH radical scavenging capacity superior to both ascorbic acid (vitamin C) and quercetin under the same assay conditions, suggesting notably potent polyphenolic antioxidant activity. Macaranga hosei methanol extract achieved a superoxide scavenging SC50 of 25.8 ppm, and nymphaeol compounds from M. tanarius inhibited protein denaturation with IC50 values of 0.26–1.02 mM; however, these are cell-free in vitro metrics and do not reflect bioavailability or antioxidant activity in living systems.
How does Macaranga compare to other antimicrobial herbs for bacterial infections?
Macaranga contains prenylated flavonoids like isomacarangin and stilbenes such as schweinfurthin B that inhibit gram-positive bacteria including S. aureus at MICs of 62.5–125 µg/mL, with effectiveness comparable to or exceeding many traditional antimicrobial herbs. The hydrophobic prenyl groups on Macaranga's compounds enhance bacterial membrane penetration, potentially offering superior bioavailability compared to non-prenylated botanical antimicrobials. Direct comparative studies against goldenseal, berberine-containing herbs, or oregano oil would clarify its relative potency in clinical settings.
What form of Macaranga extract provides the best antimicrobial activity?
Methanolic extracts of Macaranga species demonstrate strong antimicrobial and antioxidant activity, suggesting that solvent-based extractions effectively concentrate the prenylated flavonoids and stilbenes responsible for these benefits. Ethanol or methanol-based preparations are likely superior to aqueous decoctions for preserving the lipophilic prenyl-substituted compounds that enhance membrane penetration and antimicrobial potency. Standardized extracts targeting isomacarangin or schweinfurthin B content would provide more consistent antimicrobial efficacy than crude plant material.
Who would benefit most from Macaranga supplementation based on its antimicrobial properties?
Individuals with recurrent gram-positive bacterial infections, compromised immune function, or those seeking natural antimicrobial support for skin health may benefit from Macaranga's prenylated flavonoid content, particularly those unable to tolerate conventional antimicrobial agents. People with oxidative stress-related conditions could also benefit from the dual antimicrobial and antioxidant properties of M. peltata extracts. However, clinical efficacy in human populations remains to be established through rigorous trials, particularly for oral supplementation versus topical application.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w macaranga-macaranga-sp curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
